The kidney care services provider has now collected more than $105m to date, Optum Ventures co-leading a round also featuring Blue Venture Fund.
Optum Ventures, the strategic investment arm of healthcare services provider Optum, co-led a $64m series C round for US-based kidney care provider Somatus on Tuesday.
Longitude Capital and Deerfield Management co-led the round, which included Blue Venture Fund, the investment vehicle for health insurance group BlueCross BlueShield Association, in addition to Flare Capital and Town Hall Ventures.
Somatus provides vertically integrated care services to patients who are dealing with, or at risk of developing, kidney disease. It is currently active…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
